XOMA Corporation

NASDAQ XOMAO

Data sourced from iex and EODHD
Download Data

XOMA Corporation Operating Cash Flow To Current Liabilities for the Trailing 12 Months (TTM) ending March 31, 2024: -0.36

XOMA Corporation Operating Cash Flow To Current Liabilities is -0.36 for the Trailing 12 Months (TTM) ending March 31, 2024, a 32.78% change year over year. The operating cash flow to current liabilities ratio measures the ability of a company's operating cash flow to cover its current liabilities. It is calculated by dividing the operating cash flow by the current liabilities. This ratio indicates the company's short-term liquidity position and its ability to meet its immediate financial obligations using cash generated from its operations. A higher ratio suggests a stronger ability to cover current liabilities with operating cash flow.
  • XOMA Corporation Operating Cash Flow To Current Liabilities for the Trailing 12 Months (TTM) ending March 31, 2023 was -0.53.
NASDAQ: XOMAO

XOMA Corporation

CEO -
IPO Date April 12, 2021
Location United States
Headquarters 2200 Powell Street, EmeryVille, CA, United States, 94608
Employees 13
Sector Healthcare
Industry Biotechnology
Description

XOMA Corporation operates as a biotech royalty aggregator in the United States and the Asia Pacific. It has a portfolio of economic rights to future potential milestone and royalty payments associated with partnered commercial and pre-commercial therapeutic candidates. The company also focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners; and acquires milestone and royalty revenue streams on late-stage clinical or commercial assets. It has a portfolio with various assets. XOMA Corporation was incorporated in 1981 and is headquartered in Emeryville, California.

Similar companies

XOMAP

XOMA Corp

NA

NA

StockViz Staff

September 20, 2024

Any question? Send us an email